1. Barber M.: Advances in the Management of Tumor-Induced Weight Loss, www.medscape.com. 2. Inagaki J. et al.: Causes of death in cancer patients. Cancer, 1974, 33:568-573. 3. Evans W. et al.: A randomized trial of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J. Clin. Oncol., 1987, 5:113-124. 4. Ovesen L. et al.: Effect of dietary counseling on food intake, body weight, response rate, survival and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J. Clin. Oncol., 1993, 11:2043-2049. 5. American College of Physicians: Parenteral nutrition in patients receiving cancer chemotherapy. Ann. Intern. Med., 1989, 110:734-736. 6. Veterans Affair Total Parenteral Nutrition Cooperative Study Group: Perioperative total parenteral nutrition in surgical patients. N. Engl. J. Med., 1991, 325:525-532. 7. Sandstrom R. et al.: The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann. Surg., 1993, 217:185-195. 8. Brennan M.F. et al.: A prospective randomized trial of total parenteral nutrition after pancreatic resection for malignancy. Ann. Surg., 1994, 220:436-444. 9. Loprinzi C. et al.: Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J. Natl. Cancer Inst., 1990, 82:1127-1132. 10. Bruera E. etal.: A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status and other symptoms in patients with advanced cancer. Cancer, 1990, 66:1279-1282. 11. Filiu J. et al.: Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo controlled study. Am. J. Clin. Oncol., 1992, 15:436-440. 12. Tchekmedyian N. et al.: Megestrol acetate in cancer anorexia and weight loss. Cancer, 1992, 69:1268-1274. 13. Mantovani G. et al.: Managing cancer-related anorexia/cachexia. Drugs, 2000, 61:499-514. 14. Bruera E. et al.: Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Cancer Prev. Control., 1998, 2:74-78. 15. Gebbia V. etal.: Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Br. J. Cancer, 1996, 73:1576-1580. 16. Mantovani G. et al.: Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. In. J. Clin. Lab. Res., 1995, 25:135-141. 17. De Conno F. et al.: Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. Eur. J. Cancer, 1998, 34:1705-1709. 18. Buntzel J., Kuttner K.: Value of megestrol acetate in the treatment of cachexia in head-neck tumors. Laryngolorhinologie, 1995, 74:504-507. 19. Azcona C. et al.: Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumors. Aliment Pharmacol. Ther., 1996, 10:577-586. 20. Loprinzi C. etal.: Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for treatment of cancer anorexia/cachexia. J. Clin. Oncol., 1999, 17:3299-3306. 21. Jatoi A. et al.: Dranabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J. Clin. Oncol., 2002, 20:567-573. 22. Basaria S. et al.: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J. Clin. Endocrin. Metab., 2001, 86:5108-5117. 23. Kardinal C. et al.: A controlled trial of cyproterone in cancer patients with anorexia and/or cachexia. Cancer, 1990, 65:2657-2662. 24. Goldberg R. et al.: Pentoxyfilline for treatment of cancer anorexia and cachexia? A randomised, double-blind, placebo-controlled trial. J. Clin. Oncol., 1995, 13:2856-2859. 25. Loprinzi C. et al.: Randomised placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J. Clin. Oncol., 1994, 12:1121-1125. 26. Loprinzi C. et al.: Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J.Clin. Oncol., 1994, 12:1126-1125. 27. Lissoni P. et al.: Is there a role for melatonin in the treatment of neoplastic cachexia? Eur. J. Cancer, 1996, 32A:1340-1343. 28. Lundholm K. et al.: Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res., 1994, 54:5602-5606. 29. McMillan D. et al.: Effect of extended ibuprofen administration on the acute phase protein response in colorectal cancer patients. Eur. J. Surg. Oncol., 1995, 21:531-534. 30.McMillan D. et al.: Apilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients. Br. J. Cancer., 1997, 76:788-790. 31.McMillan D. et al.: A prospective randomised study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br. J. Cancer, 1999, 79:495-500. 32. Wigmore S. et al.: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition, 1996, 12(supl.1):S27-S30. 33.Wigmore S. et al.: Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr. Cancer, 2000, 36:177-184. 34.Gogos C. et al.: Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. A randomised controlled trial. Cancer, 1998, 82:395-402.